BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jayachandran I, Sundararajan S, Venkatesan S, Paadukaana S, Balasubramanyam M, Mohan V, Manickam N. Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway. Sci Rep 2020;10:16005. [PMID: 32994511 DOI: 10.1038/s41598-020-72943-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kou L, Kou P, Luo G, Wei S, Tejero J. Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/6197219] [Reference Citation Analysis]
2 Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Toxins (Basel) 2021;13:142. [PMID: 33668632 DOI: 10.3390/toxins13020142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhao Y, Zhang M, Dou Y, Du K, Liu X, Zhao Y, Wang F. DDAH1/ADMA Regulates Adiponectin Resistance in Cerebral Ischemia via the ROS/FOXO1/APR1 Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/2350857] [Reference Citation Analysis]
4 Harrison DG, Coffman TM, Wilcox CS. Pathophysiology of Hypertension: The Mosaic Theory and Beyond. Circ Res 2021;128:847-63. [PMID: 33793328 DOI: 10.1161/CIRCRESAHA.121.318082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Basir SS, Mirzaei B. Effects of moderate-intensity concurrent exercise training on cardiovascular risk factors in patients with chronic kidney disease undergoing hemodialysis: a randomized control trial. Sport Sci Health. [DOI: 10.1007/s11332-022-00911-6] [Reference Citation Analysis]